cerrar
Tagged with ALS

Karel Van De Sompel – Country Manager, Pfizer Belgium…
Karel Van De Sompel, country manager of Pfizer in Belgium and Luxembourg and chairman of Pharma.be, highlights the key changes he sees in today’s…

Stéphane De Wit – Head, Department of Infectious Diseases,…
Professor Stéphane De Wit, head of the Department of Infectious Diseases at St Pierre University Hospital outlines Belgium’s approach to tackling…

Roman Grunt – CEO, Quinta Analytica, Czech Republic
Roman Grunt, CEO of Quinta Analytica, gives us an overview of the activities of how the Czech firm has managed to attract customers across the country…

Anne-Laure Dreno – Country President, AstraZeneca Belgium…
Anne-Laure Dreno, country president of AstraZeneca in Belgium, elaborates on the significant position Belgium and the local affiliate have for the…

Miguel Forte – CEO, Bone Therapeutics, Belgium
Miguel Forte, CEO of Bone Therapeutics, walks through his journey leading the promising Belgian biotech company. He also shares with his view of the…

Sweden: An Innovation Nation
Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10 million and marginal positioning on the northerly fringe of the European…

Reem Osman – CEO, Saudi German Hospitals UAE
The Saudi German Hospital Group is one of the leading hospital groups in the Middle East, with hospitals in the UAE, Saudi Arabia, Yemen and Egypt. Dr…

Sanaa Sayagh – General Manager, Roche Morocco
Sanaa Sayagh of Roche Morocco shares her commitment to bringing the latest immunotherapies to Moroccan patients through partnerships with health…

Pavla Nevolová – Country Head, EastHORN Czech Republic
Pavla Nevolová, country head of EastHORN in the Czech Republic, shares the historical roots of the now multinational Czech CRO. Nevolová also shares…

Czech Clinical Trials: Finding the Niches
The Czech Republic boasts a solid clinical research infrastructure and a supportive regulatory environment, meaning that it stands out as one of…

Belgium: Punching Well Above its Weight in Clinical Trials
Despite a population size of only 11.4 million (ninth in Europe), Belgium is the continent’s fifth biggest spender on R&D, behind only Germany,…

The UK: The G7’s Hottest Life Science Investment Destination?
With Brexit now confirmed, the UK government has been playing up the country’s scientific credentials. The aim is to cement the UK’s position as…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here